Experiment 831428
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | MACBETH,FR:. (1982). VM26: PHASE I AND II STUDIES.. 7() |
| Amount utilized | |
| Compound isolated | |
| Disease | THIS PAPER REVIEWS THE PHASE I AND II STUDIES OF TENIPOSIDE IN CANCER TREATMENT. TENIPOSIDE IS EFFECTIVE IN TREATING HODGKIN'S DISEASE, NON-HODGKIN'S LYMPHOMA, NEUROBLASTOMA, PRIMARY BRAIN TUMORS AND SMALL CELL CARCINOMA OF THE LUNG. IT SHOWED SOME ACTIVITY IN INTESTINAL CANCERS, BREAST CANCER AND AL LEUKEMIA IN CHILDREN. THE DOSE LIMITING TOXICITY IS BONE MARROW SUPPRESSION. LESS COMMON TOXICITY INCLUDE HYPOTENSION, SEIZURE, ANAPHYLAXIS, RAISED SERUM SGOT AND HYPERTHERMIA. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |